The P236L Delavirdine-Resistant Human Immunodeficiency Virus Type 1 Mutant Is Replication Defective and Demonstrates Alterations in both RNA 5′-End- and DNA 3′-End-Directed RNase H Activities

類似資料

• Mutants of Human Immunodeficiency Virus Type 1 (HIV-1) Reverse Transcriptase Resistant to Nonnucleoside Reverse Transcriptase Inhibitors Demonstrate Altered Rates of RNase H Cleavage That Correlate with HIV-1 Replication Fitness in Cell Culture
  著者:: Archer, Richard H., 等
  出版事項: (2000)
• Delavirdine Susceptibilities and Associated Reverse Transcriptase Mutations in Human Immunodeficiency Virus Type 1 Isolates from Patients in a Phase I/II Trial of Delavirdine Monotherapy (ACTG 260)
  著者:: Demeter, L. M., 等
  出版事項: (2000)
• ACTG 260: a Randomized, Phase I-II, Dose-Ranging Trial of the Anti-Human Immunodeficiency Virus Activity of Delavirdine Monotherapy
  著者:: Para, Michael F., 等
  出版事項: (1999)
• Determinants of the RNase H cleavage specificity of human immunodeficiency virus reverse transcriptase.
  著者:: DeStefano, J J, 等
  出版事項: (1993)
• Madurahydroxylactone Derivatives as Dual Inhibitors of Human Immunodeficiency Virus Type 1 Integrase and RNase H
  著者:: Marchand, Christophe, 等
  出版事項: (2008)